Proxy Votes Now

Home › Funds › Equitable › Multimanager Aggressive Equity Portfolio

Multimanager Aggressive Equity Portfolio proxy voting record 2025-2026

Fund family: Equitable · Filed by EQ ADVISORS TRUST (CIK 1027263) · SEC series S000044691

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 7,870 with, 209 against, 31 abstentions (not counted as with management); 6 items carried no recommendation; 104 split votes are in neither count. Shareholder proposals: 62 FOR, 122 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Equitable as a whole

The same two figures as Equitable’s manager page (393,894 ballot items across 72 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsEquitableItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)85.1%7,72592.5%339,726
Backed environmental and social shareholder proposals at US companies10.7%849.6%3,486

Where this fund voted differently from most Equitable funds

Each ballot item this fund voted is set against the votes of the other Equitable funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Equitable funds on 750 items (9.5% of the 7,925 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Equitable fundsMgmtResult
Dayforce, Inc.2025-11-12A proposal to adopt the Agreement and Plan of Merger, dated as of August 20, 2025 (the "merger agreement"), by and among Dayforce, Inc. ("Dayforce"), Dawn Bidco, LLC and Dawn Acquisition Merger Sub, Inc.AgainstFOR — 22 of 22 Equitable fundsAgainstApproved, 88.4% support
Dayforce, Inc.2025-11-12A proposal to approve any adjournment of the special meeting for the purpose of soliciting additional proxies if there are insufficient votes at the special meeting to adopt the merger agreement.AgainstFOR — 22 of 22 Equitable fundsAgainst—
Dayforce, Inc.2025-11-12A proposal to approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Dayforce's named executive officers in connection with the transactions contemplated by the merger agreement, including consummation of the merger.AgainstFOR — 22 of 22 Equitable fundsAgainst—
Morgan Stanley2026-05-14Shareholder Shareholder proposal requesting an independent Board ChairmanForAGAINST — 16 of 17 Equitable fundsAgainstFailed (calculated), 27.3% support
T-Mobile US, Inc.2026-06-16Advisory Vote to Approve the Compensation Provided to the Company's Named Executive Officers for 2025.ForAGAINST — 15 of 17 Equitable fundsForApproved, 73.3% support
T-Mobile US, Inc.2026-06-16Election of Directors: Christian P. IllekForWITHHOLD — 12 of 16 Equitable fundsForPassed (calculated), 78.9% support
T-Mobile US, Inc.2026-06-16Election of Directors: Dominique LeroyForWITHHOLD — 12 of 16 Equitable fundsForPassed (calculated), 78.3% support
T-Mobile US, Inc.2026-06-16Election of Directors: Raphael KublerForWITHHOLD — 12 of 16 Equitable fundsForPassed (calculated), 78.3% support
Astera Labs, Inc.2026-06-04To elect three Class II directors to our board of directors to serve until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Michael HurlstonForWITHHOLD — 4 of 4 Equitable fundsAgainstElected, 68.3% support
Roku, Inc.2026-06-11To elect three Class III directors to serve until the 2029 Annual Meeting of Stockholders: Jeffrey HastingsForWITHHOLD — 6 of 7 Equitable fundsAgainstPassed (calculated), 83.8% support
Praxis Precision Medicines, Inc.2026-06-10To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Gregory NordenWithholdFOR — 8 of 10 Equitable fundsAgainstPassed (calculated), 98.8% support
Praxis Precision Medicines, Inc.2026-06-10To elect the Class III Directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: William YoungWithholdFOR — 8 of 10 Equitable fundsAgainstPassed (calculated), 85.5% support
Dutch Bros Inc.2026-05-13Election of Directors: Stephen GillettForAGAINST — 6 of 7 Equitable fundsAgainstElected, 92.0% support
Dutch Bros Inc.2026-05-13Election of Directors: Todd PenegorForAGAINST — 6 of 7 Equitable fundsAgainstElected, 91.7% support
CompoSecure, Inc.2025-12-23To approve the issuance of CompoSecure's Class A Common Stock, par value $0.0001 per share, in connection with the transactions contemplated by, and pursuant to the terms of, the Share Purchase Agreement (as it may be amended from time to time, the "Transaction Agreement") that we and certain of ourAbstainFOR — 6 of 7 Equitable fundsAgainstApproved, 100.0% support
Amylyx Pharmaceuticals, Inc.2026-06-04Election of Directors: To elect the following persons to our board of directors, each to serve as a Class II director until the 2029 Annual Meeting of Stockholders and until their successor has been duly elected and qualified, or until such director's earlier death, resignation or removal: George McWithholdFOR — 6 of 7 Equitable fundsAgainstPassed (calculated), 84.5% support
Amylyx Pharmaceuticals, Inc.2026-06-04To approve, on a non-binding, advisory basis, the compensation of our named executive officers.AgainstFOR — 6 of 7 Equitable fundsAgainstApproved, 85.2% support
Palvella Therapeutics, Inc.2026-06-10Approval of an amendment to the 2024 Equity Incentive Plan to increase the authorized shares issuable under the 2024 Plan by 750,000 shares.AgainstFOR — 6 of 7 Equitable fundsAgainst—
Palvella Therapeutics, Inc.2026-06-10Election of three director nominees to serve as Class III directors whose term will expire in 2029: Todd C. DavisWithholdFOR — 6 of 7 Equitable fundsAgainstPassed (calculated), 81.8% support
Nuvation Bio Inc.2026-05-21Election of Directors: Robert BazemoreWithholdFOR — 6 of 7 Equitable fundsAgainstElected, 84.0% support
Nuvation Bio Inc.2026-05-21Election of Directors: Robert Mashal, M.D.WithholdFOR — 6 of 7 Equitable fundsAgainstElected, 92.1% support
OneSpan Inc.2026-06-05To elect seven directors to serve on the Board of Directors: Michael McConnellAgainstFOR — 6 of 7 Equitable fundsAgainstElected, 81.6% support
International Money Express, Inc.2025-12-09To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Intermex's named executive officers that is based on or otherwise relates to the Merger Agreement and/or the transactions contemplated by the Merger Agreement.AgainstFOR — 6 of 7 Equitable fundsAgainstApproved, 75.1% support
WK Kellogg Co.2025-09-19The Adjournment Proposal - To approve one or more adjournments of the special meeting, if necessary, to solicit additional proxies if a quorum is not present or there are not sufficient votes cast at the special meeting to approve the Merger Proposal.AbstainFOR — 6 of 7 Equitable fundsAgainst—
Targa Resources Corp.2026-05-21To elect the four Class I Directors named in the proxy statement, each to serve until the 2029 annual meeting of stockholders: Charles R. CrispAgainstFOR — 13 of 19 Equitable fundsAgainstElected, 96.4% support
Show the next 475
Items 26 to 500.
CompanyMeetingItemThis fundMost Equitable fundsMgmtResult
Targa Resources Corp.2026-05-21To elect the four Class I Directors named in the proxy statement, each to serve until the 2029 annual meeting of stockholders: Laura C. FultonAgainstFOR — 13 of 19 Equitable fundsAgainstElected, 87.2% support
Targa Resources Corp.2026-05-21To elect the four Class I Directors named in the proxy statement, each to serve until the 2029 annual meeting of stockholders: Paul W. ChungAgainstFOR — 13 of 19 Equitable fundsAgainstElected, 94.0% support
Targa Resources Corp.2026-05-21To elect the four Class I Directors named in the proxy statement, each to serve until the 2029 annual meeting of stockholders: R. Keith TeagueAgainstFOR — 13 of 19 Equitable fundsAgainstElected, 96.9% support
Cogent Biosciences, Inc.2026-06-09Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Arlene M. MorrisWithholdFOR — 7 of 9 Equitable fundsAgainstElected, 83.9% support
Cogent Biosciences, Inc.2026-06-09Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Dr. Chris CainWithholdFOR — 7 of 9 Equitable fundsAgainstElected, 86.8% support
Cogent Biosciences, Inc.2026-06-09Election of the three Class II director nominees to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Todd ShegogWithholdFOR — 7 of 9 Equitable fundsAgainstElected, 86.7% support
Snowflake Inc.2025-07-02To approve, on a non-binding advisory basis, the compensation of our named executive officers.ForAGAINST — 5 of 6 Equitable fundsAgainstNot approved, 30.2% support
Spyre Therapeutics, Inc.2026-05-272 wordings Election of Class I Directors for terms expiring in 2029: Mark McKennaWithholdFOR — 5 of 6 Equitable fundsAgainstPassed (calculated), 98.0% support
Mercury Systems, Inc.2025-10-22To elect three Class I directors nominated by the Board of Directors, each to serve for a three-year term, and in each case until their successors have been duly elected and qualified: Howard L. LanceWithholdFOR — 5 of 6 Equitable fundsAgainst—
Tarsus Pharmaceuticals, Inc.2026-06-25To elect Class III directors, to serve until the 2029 annual meeting of stockholders or until their respective successors have been elected or appointed: Andrew GoldbergWithholdFOR — 5 of 6 Equitable fundsAgainstElected, 76.9% support
Enliven Therapeutics, Inc.2026-06-09To elect the two Class III directors named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Lori Kunkel, M.D.WithholdFOR — 5 of 6 Equitable fundsAgainstElected, 64.7% support
Legence Corp.2026-06-11Election of Directors: Bilal KhanWithholdFOR — 5 of 6 Equitable fundsAgainstElected, 78.6% support
Astronics Corporation2026-05-28To elect nine directors to hold office until the 2027 Annual Meeting and until their successors have been elected and qualified: Fay WestWithholdFOR — 5 of 6 Equitable fundsAgainstElected, 97.5% support
Astronics Corporation2026-05-28To elect nine directors to hold office until the 2027 Annual Meeting and until their successors have been elected and qualified: Jeffry D. FrisbyWithholdFOR — 5 of 6 Equitable fundsAgainstElected, 99.3% support
Astronics Corporation2026-05-28To elect nine directors to hold office until the 2027 Annual Meeting and until their successors have been elected and qualified: Linda G. O'BrienWithholdFOR — 5 of 6 Equitable fundsAgainstElected, 83.5% support
Astronics Corporation2026-05-28To elect nine directors to hold office until the 2027 Annual Meeting and until their successors have been elected and qualified: Mark MoranWithholdFOR — 5 of 6 Equitable fundsAgainstElected, 76.2% support
Astronics Corporation2026-05-28To elect nine directors to hold office until the 2027 Annual Meeting and until their successors have been elected and qualified: Neil Y. KimWithholdFOR — 5 of 6 Equitable fundsAgainstElected, 99.4% support
Astronics Corporation2026-05-28To elect nine directors to hold office until the 2027 Annual Meeting and until their successors have been elected and qualified: Peter J. GundermannWithholdFOR — 5 of 6 Equitable fundsAgainstElected, 98.9% support
Astronics Corporation2026-05-28To elect nine directors to hold office until the 2027 Annual Meeting and until their successors have been elected and qualified: Robert S. KeaneWithholdFOR — 5 of 6 Equitable fundsAgainstElected, 78.6% support
Astronics Corporation2026-05-28To elect nine directors to hold office until the 2027 Annual Meeting and until their successors have been elected and qualified: Robert T. BradyWithholdFOR — 5 of 6 Equitable fundsAgainstElected, 93.1% support
Astronics Corporation2026-05-28To elect nine directors to hold office until the 2027 Annual Meeting and until their successors have been elected and qualified: Warren C. JohnsonWithholdFOR — 5 of 6 Equitable fundsAgainstElected, 83.6% support
Ardent Health, Inc.2026-05-20Election of Directors: Peter BynoeForWITHHOLD — 5 of 6 Equitable fundsForPassed (calculated), 95.2% support
Immunome, Inc.2026-06-09To elect the three nominees named in the Proxy Statement to serve as Class III directors, to hold office until the 2029 Annual Meeting of Stockholders and such time as their successors are duly elected and qualified, or until their earlier death, resignation or removal: James BoylanWithholdFOR — 5 of 6 Equitable fundsAgainstElected, 76.0% support
IDT Corporation2025-12-11Election of Directors: Elaine S. YatzkanAgainstFOR — 5 of 6 Equitable fundsAgainstElected, 91.4% support
IDT Corporation2025-12-11Election of Directors: Howard S. JonasAgainstFOR — 5 of 6 Equitable fundsAgainstElected, 89.8% support
IDT Corporation2025-12-11Election of Directors: Irwin KatsofAgainstFOR — 5 of 6 Equitable fundsAgainstElected, 90.9% support
IDT Corporation2025-12-11Election of Directors: Judah SchorrAgainstFOR — 5 of 6 Equitable fundsAgainstElected, 88.0% support
Maze Therapeutics, Inc.2026-06-08Election of Class I Directors: Neil Kumar, Ph.D.WithholdFOR — 5 of 6 Equitable fundsAgainstElected, 81.6% support
Triumph Financial, Inc.2026-04-23Management Proposal Regarding Advisory Approval of the Company's Executive CompensationAgainstFOR — 5 of 6 Equitable fundsAgainstPassed (calculated), 70.9% support
Ivanhoe Electric Inc.2026-06-04Election of Directors: Priya PatilForAGAINST — 5 of 6 Equitable fundsForPassed (calculated), 80.1% support
Ivanhoe Electric Inc.2026-06-04Election of Directors: Russell BallAgainstFOR — 5 of 6 Equitable fundsAgainstPassed (calculated), 97.4% support
Ivanhoe Electric Inc.2026-06-04Election of Directors: Sofia BianchiAgainstFOR — 5 of 6 Equitable fundsAgainstPassed (calculated), 89.8% support
Metsera, Inc.2025-11-13To adjourn the Special Meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting.AbstainFOR — 5 of 6 Equitable fundsAgainst—
Metsera, Inc.2025-11-13To adopt the Agreement and Plan of Merger, dated as of September 21, 2025 (as it may be amended from time to time, the "Merger Agreement"), by and among Pfizer Inc., a Delaware corporation ("Parent"), Mayfair Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent ("Merger SAbstainFOR — 5 of 6 Equitable fundsAgainstApproved, 100.0% support
Sionna Therapeutics, Inc.2026-06-17To elect four class II directors to serve until our 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Peter A. Thompson, M.D.WithholdFOR — 5 of 6 Equitable fundsAgainst—
Phillips 662026-05-13Election of four Class III Directors named in this Proxy Statement to hold office until the 2029 Annual Meeting: Gregory J. HayesAgainstFOR — 13 of 21 Equitable fundsAgainstPassed (calculated), 91.2% support
Workday, Inc.2026-06-16Election of Class II Directors: Mark J. HawkinsAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 93.4% support
Workday, Inc.2026-06-16Election of Class II Directors: Rhonda J. MorrisAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 99.3% support
Live Nation Entertainment, Inc.2026-06-11To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Carl VogelAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 99.8% support
Live Nation Entertainment, Inc.2026-06-11To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Chad HollingsworthAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 94.9% support
Live Nation Entertainment, Inc.2026-06-11To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: James IovineAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 98.4% support
Live Nation Entertainment, Inc.2026-06-11To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: James S. KahanAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 98.8% support
Live Nation Entertainment, Inc.2026-06-11To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Jeffrey T. HinsonAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 98.6% support
Live Nation Entertainment, Inc.2026-06-11To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Latriece WatkinsAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 98.4% support
Live Nation Entertainment, Inc.2026-06-11To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Ping FuAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 99.6% support
Live Nation Entertainment, Inc.2026-06-11To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Randall T. MaysAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 97.0% support
Live Nation Entertainment, Inc.2026-06-11To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Richard A. GrenellAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 99.8% support
Live Nation Entertainment, Inc.2026-06-11To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Richard A. PaulAgainstFOR — 11 of 17 Equitable fundsAgainstElected, 99.7% support
Live Nation Entertainment, Inc.2026-06-11To hold an advisory vote on the company's executive compensation;AgainstFOR — 11 of 17 Equitable fundsAgainstPassed (calculated), 86.8% support
Tractor Supply Company2026-05-14To approve, on a non-binding, advisory basis, the compensation of the named executive officers of the Company (Say on Pay)AgainstFOR — 12 of 19 Equitable fundsAgainstApproved, 86.0% support
Entegris, Inc.2026-05-06Shareholder Stockholder Proposal: Providing stockholders the right to call special meetings of stockholders.AgainstFOR — 6 of 8 Equitable fundsAgainstFailed (calculated), 31.3% support
Entegris, Inc.2026-05-06To approve, on an advisory basis, providing stockholders the right to call special meetings of stockholders.ForAGAINST — 6 of 8 Equitable fundsAgainstPassed (calculated), 83.6% support
Red Rock Resorts, Inc.2026-06-04Advisory vote to approve the compensation of our named executive officers.AgainstFOR — 6 of 8 Equitable fundsAgainst—
Alphabet Inc.2026-06-05Election of ten directors: Frances H. ArnoldAgainstFOR — 14 of 24 Equitable fundsAgainstElected, 90.1% support
Tesla, Inc.2025-11-06A Tesla proposal for approval of the A&R 2019 Equity Incentive Plan.AgainstFOR — 13 of 22 Equitable fundsAgainstApproved, 79.1% support
T-Mobile US, Inc.2026-06-16Election of Directors: G. Michael SievertForWITHHOLD — 10 of 16 Equitable fundsForPassed (calculated), 90.2% support
The Charles Schwab Corporation2026-05-21Election of directors for three-year terms: Frank C. HerringerAgainstFOR — 13 of 22 Equitable fundsAgainstElected, 84.3% support
Adobe Inc.2026-04-15Election of the eleven (11) Directors proposed in the accompanying Proxy Statement to serve for a one-year term: Frank CalderoniAgainstFOR — 10 of 16 Equitable fundsAgainstPassed (calculated), 88.6% support
Carvana Co.2026-05-05Shareholder To vote upon one stockholder proposal, as described in the Proxy Statement.ForAGAINST — 10 of 16 Equitable fundsAgainstNot approved, 3.9% support
DoorDash, Inc.2026-06-10The election of the following director nominee(s): Shona L. BrownAgainstFOR — 10 of 16 Equitable fundsAgainstElected, 89.8% support
Workday, Inc.2026-06-16Election of Class II Directors: George J. Still, Jr.AgainstFOR — 11 of 18 Equitable fundsAgainstElected, 97.0% support
Zoetis Inc.2026-05-20Shareholder Shareholder proposal to permit shareholder action by written consent.ForAGAINST — 12 of 20 Equitable fundsAgainst—
Corpay, Inc.2026-05-07Shareholder Shareholder proposal regarding an independent Board Chair requirement, if properly presented at the meeting.ForAGAINST — 10 of 16 Equitable fundsAgainstFailed (calculated), 30.0% support
FactSet Research Systems Inc.2025-12-18To approve the FactSet Research Systems Inc. 2025 Omnibus Incentive Plan.AgainstFOR — 12 of 20 Equitable fundsAgainst—
FactSet Research Systems Inc.2025-12-18To elect ten directors to the Board of Directors: Robin A. Abrams, Siew Kai Choy, Barak Eilam, Malcolm Frank, Laurie G. Hylton, Lee Shavel, Laurie Siegel, Maria Teresa Tejada, Sanoke Viswanathan, and Elisha Wiesel each be elected to serve a one-year term expiring in concurrence with the Annual MeetiAgainstFOR — 12 of 20 Equitable fundsAgainstElected, 94.1% support
FactSet Research Systems Inc.2025-12-18To elect ten directors to the Board of Directors: Robin A. Abrams, Siew Kai Choy, Barak Eilam, Malcolm Frank, Laurie G. Hylton, Lee Shavel, Laurie Siegel, Maria Teresa Tejada, Sanoke Viswanathan, and Elisha Wiesel each be elected to serve a one-year term expiring in concurrence with the Annual MeetiAgainstFOR — 12 of 20 Equitable fundsAgainstElected, 98.2% support
FactSet Research Systems Inc.2025-12-18To elect ten directors to the Board of Directors: Robin A. Abrams, Siew Kai Choy, Barak Eilam, Malcolm Frank, Laurie G. Hylton, Lee Shavel, Laurie Siegel, Maria Teresa Tejada, Sanoke Viswanathan, and Elisha Wiesel each be elected to serve a one-year term expiring in concurrence with the Annual MeetiAgainstFOR — 12 of 20 Equitable fundsAgainstElected, 98.2% support
FactSet Research Systems Inc.2025-12-18To elect ten directors to the Board of Directors: Robin A. Abrams, Siew Kai Choy, Barak Eilam, Malcolm Frank, Laurie G. Hylton, Lee Shavel, Laurie Siegel, Maria Teresa Tejada, Sanoke Viswanathan, and Elisha Wiesel each be elected to serve a one-year term expiring in concurrence with the Annual MeetiAgainstFOR — 12 of 20 Equitable fundsAgainstElected, 98.1% support
Lennox International Inc.2026-05-21To elect three Class I directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders: Karen H. QuintosAgainstFOR — 10 of 16 Equitable fundsAgainstPassed (calculated), 93.2% support
Xometry, Inc.2026-06-16To elect three Class II directors, each to hold office until the Company's Annual Meeting of Stockholders in 2029: Roy AzevedoWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 99.7% support
Rush Enterprises, Inc.2026-05-19Election of Directors: Amy BoergerWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 99.2% support
Rush Enterprises, Inc.2026-05-19Election of Directors: Dr. Kennon H. GuglielmoWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 78.3% support
Rush Enterprises, Inc.2026-05-19Election of Directors: Michael J. McRobertsWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 99.6% support
Rush Enterprises, Inc.2026-05-19Election of Directors: Raymond J. ChessWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 77.9% support
Rush Enterprises, Inc.2026-05-19Election of Directors: Thomas A. AkinWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 98.8% support
Rush Enterprises, Inc.2026-05-19Election of Directors: Troy A. ClarkeWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 78.3% support
Rush Enterprises, Inc.2026-05-19Election of Directors: W. M. Rusty RushWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 99.3% support
Rush Enterprises, Inc.2026-05-19Election of Directors: William H. CaryWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 99.0% support
Alliance Laundry Holdings Inc.2026-06-11To elect Michael D. Schoeb, Phyllis A. Knight and Robert L. Verigan as Class I directors to serve until the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Robert L. VeriganWithholdFOR — 4 of 5 Equitable fundsAgainst—
Adaptive Biotechnologies Corporation2026-06-05To elect two Class I director nominees to serve on the board of directors of Adaptive Biotechnologies Corporation for a three-year term expiring at the 2029 annual meeting of shareholders: Robert Hershberg, PhD, MDWithholdFOR — 4 of 5 Equitable fundsAgainst—
Interparfums, Inc.2025-09-10Election of Directors: Robert BensoussanWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 94.8% support
Interparfums, Inc.2025-09-10Election of Directors: Veronique Gabai-PinskyWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 97.4% support
Pulse Biosciences, Inc.2025-12-09Election of Directors: Manmeet S. SoniAbstainFOR — 4 of 5 Equitable fundsAgainstElected, 99.5% support
Pulse Biosciences, Inc.2025-12-09Election of Directors: Robert W. DugganAbstainFOR — 4 of 5 Equitable fundsAgainstElected, 97.5% support
The Vita Coco Company, Inc.2026-06-03Election of Class II Directors: Kenneth SadowskyWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 80.8% support
Nicolet Bankshares, Inc.2026-05-18Approval, on a non-binding advisory basis, of the compensation paid to Nicolet's named executive officers.AgainstFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 67.1% support
Nicolet Bankshares, Inc.2026-05-18NOMINEES: John N. DykemaWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 91.0% support
Dave Inc.2026-06-02Director Election: Dan PrestonWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 86.4% support
American States Water Company2026-05-19Election of Class III Directors: Mr. C. James LevinWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 94.9% support
American States Water Company2026-05-19Election of Class III Directors: Mr. Roger M. ErvinWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 98.7% support
American States Water Company2026-05-19Election of Class III Directors: Mr. Thomas A. EichelbergerWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 98.8% support
Warby Parker Inc.2026-06-08Election of Directors: David ("Dave") GilboaWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 98.9% support
Warby Parker Inc.2026-06-08Election of Directors: Ronald WilliamsWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 91.5% support
Warby Parker Inc.2026-06-08Election of Directors: Youngme MoonWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 99.3% support
SiriusPoint Ltd.2026-05-20Election of two Class 1 director nominees for 3-year terms expiring in 2029: Susan L. CrossWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 97.3% support
MGE Energy, Inc.2026-05-19Election of Class I Directors: Angela S. RiegerAgainstFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 98.5% support
MGE Energy, Inc.2026-05-19Election of Class I Directors: James G. BerbeeAgainstFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 97.9% support
MGE Energy, Inc.2026-05-19Election of Class I Directors: Londa J. DeweyAgainstFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 96.9% support
Constellium SE2026-05-21Re-appointment of Mr. John Ormerod as a director for a term of three yearsAgainstFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 83.8% support
USA Rare Earth, Inc.2026-06-03Election of Directors: Carolyn TrabucoWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 86.1% support
USA Rare Earth, Inc.2026-06-03Election of Directors: Michael BlitzerWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 85.1% support
NovaGold Resources Inc.2026-05-14Approval of Non-Binding Advisory Vote on Executive Compensation To consider and, if deemed advisable, pass a non-binding resolution approving the compensation of the Company's Named Executive Officers.AgainstFOR — 4 of 5 Equitable fundsAgainstApproved, 72.5% support
NovaGold Resources Inc.2026-05-14Election of Directors: Daniel Muniz QuintanillaWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 91.4% support
NovaGold Resources Inc.2026-05-14Election of Directors: Dawn WhittakerWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 97.5% support
NovaGold Resources Inc.2026-05-14Election of Directors: Dr. Elaine Dorward-KingWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 91.5% support
NovaGold Resources Inc.2026-05-14Election of Directors: Dr. Thomas KaplanWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 97.1% support
NovaGold Resources Inc.2026-05-14Election of Directors: Ethan SchuttWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 97.3% support
NovaGold Resources Inc.2026-05-14Election of Directors: Hume KyleWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 98.8% support
NovaGold Resources Inc.2026-05-14Election of Directors: Kalidas MadhavpeddiWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 88.8% support
NovaGold Resources Inc.2026-05-14Election of Directors: Kevin McArthurWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 99.5% support
Grindr Inc.2025-07-30Election of Directors: J. Michael Gearon, Jr.WithholdFOR — 4 of 5 Equitable fundsAgainstElected, 93.7% support
Grindr Inc.2025-07-30Election of Directors: James Fu Bin LuWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 93.6% support
Grindr Inc.2025-07-30Election of Directors: Meghan StablerForWITHHOLD — 4 of 5 Equitable fundsForElected, 93.8% support
Grindr Inc.2025-07-30Election of Directors: Nathan RichardsonForWITHHOLD — 4 of 5 Equitable fundsForElected, 93.8% support
Ouster, Inc.2026-06-17Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers.AgainstFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 79.9% support
Pitney Bowes Inc.2026-05-12Election of Directors: Wayne WalkerAgainstFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 91.6% support
Sonic Automotive, Inc.2026-04-29Election of Directors: B. Scott SmithAgainstFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 93.3% support
Sonic Automotive, Inc.2026-04-29Election of Directors: David Bruton SmithAgainstFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 93.3% support
Sonic Automotive, Inc.2026-04-29Election of Directors: Jeff DykeAgainstFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 96.8% support
Sonic Automotive, Inc.2026-04-29Election of Directors: Keri A. KaiserAgainstFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 92.1% support
Sonic Automotive, Inc.2026-04-29Election of Directors: Marcus G. SmithAgainstFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 93.3% support
Sonic Automotive, Inc.2026-04-29Election of Directors: Michael HodgeAgainstFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 93.3% support
Sonic Automotive, Inc.2026-04-29Election of Directors: William R. BrooksAgainstFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 93.0% support
Innospec Inc.2026-05-08Election of two Class I Directors: Claudia P. PocciaWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 93.4% support
Innospec Inc.2026-05-08Election of two Class I Directors: Elizabeth K. ArnoldWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 91.4% support
Trevi Therapeutics, Inc.2026-06-03Election of one Class I director to our Board of Directors, to serve until the 2029 Annual Meeting of Stockholders: Michael HeffernanWithholdFOR — 4 of 5 Equitable fundsAgainst—
Kaiser Aluminum Corporation2026-06-04Election of Directors: BRETT E. WILCOXWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 96.1% support
Kaiser Aluminum Corporation2026-06-04Election of Directors: GLENDA J. MINORWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 98.1% support
Pathward Financial, Inc.2026-02-24Election of Directors: Christopher PerrettaWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 94.1% support
Pathward Financial, Inc.2026-02-24Election of Directors: Douglas J. HajekWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 96.6% support
Pathward Financial, Inc.2026-02-24Election of Directors: Kendall E. StorkWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 93.9% support
Mineralys Therapeutics, Inc.2026-05-21Election of Class III directors for a three-year term to expire at the 2029 annual meeting of stockholders: Brian Taylor Slingsby, M.D., Ph.D., M.P.H.ForWITHHOLD — 4 of 5 Equitable fundsForPassed (calculated), 63.3% support
Taysha Gene Therapies, Inc.2026-06-01To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.AgainstFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 82.2% support
Sylvamo Corporation2026-05-15Elect the seven director nominees named in the proxy statement to our Board of Directors: David PetratisAgainstFOR — 4 of 5 Equitable fundsAgainstElected, 92.7% support
Middlesex Water Company2026-05-19Election of Directors: James F. Cosgrove, Jr.WithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 95.3% support
Middlesex Water Company2026-05-19Election of Directors: Joshua Bershad, MDWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 95.1% support
Middlesex Water Company2026-05-19Election of Directors: Vaughn L. McKoyWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 79.7% support
Amprius Technologies, Inc.2026-06-11Election of Class I Directors: Kathleen BaylessWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 71.4% support
IRadimed Corporation2026-06-23Election of Directors: Monty AllenForWITHHOLD — 4 of 5 Equitable fundsForElected, 87.3% support
Fluence Energy, Inc.2026-03-12To elect the following twelve (12) directors to hold office until the Company's 2027 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Fahad Al-DarwishWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 95.8% support
Fluence Energy, Inc.2026-03-12To elect the following twelve (12) directors to hold office until the Company's 2027 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: John Christopher ("Chris") SheltonWithholdFOR — 4 of 5 Equitable fundsAgainst—
Fluence Energy, Inc.2026-03-12To elect the following twelve (12) directors to hold office until the Company's 2027 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Peter Chi-Shun LukWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 95.8% support
Syndax Pharmaceuticals, Inc.2026-06-10Election of Directors: Michael A. MetzgerWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 98.9% support
Syndax Pharmaceuticals, Inc.2026-06-10Election of Directors: Pierre LegaultWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 63.5% support
Syndax Pharmaceuticals, Inc.2026-06-10To approve the Syndax Pharmaceuticals, Inc. 2026 Equity Incentive Plan.AgainstFOR — 4 of 5 Equitable fundsAgainst—
Atlas Energy Solutions Inc.2026-05-07Election to the Company's Board of Directors of the two Class III directors set forth in the accompanying proxy statement, each of whom will hold office until the 2029 Annual Meeting of Stockholders and until their successor is elected and qualified or until their earlier death, resignation or removWithholdFOR — 4 of 5 Equitable fundsAgainstElected, 88.5% support
Priority Technology Holdings, Inc.2026-06-11Election of Directors: Marc CrisafulliAgainstFOR — 4 of 5 Equitable fundsAgainstElected, 99.0% support
Priority Technology Holdings, Inc.2026-06-11Election of Directors: Michael PassillaForAGAINST — 4 of 5 Equitable fundsForElected, 98.2% support
Camping World Holdings, Inc.2026-05-21Approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers.AgainstFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 95.0% support
Camping World Holdings, Inc.2026-05-21Election of Class I Directors: K. Dillon SchickliWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 93.0% support
Camping World Holdings, Inc.2026-05-21Election of Class I Directors: Mary J. GeorgeWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 96.8% support
Capricor Therapeutics, Inc.2026-06-04ELECTION OF DIRECTORS: Frank LitvackForWITHHOLD — 4 of 5 Equitable fundsForPassed (calculated), 68.6% support
Build-A-Bear Workshop, Inc.2026-06-11Election of Directors: Lesli RotenbergAgainstFOR — 4 of 5 Equitable fundsAgainstElected, 93.1% support
Build-A-Bear Workshop, Inc.2026-06-11Election of Directors: Narayan IyengarAgainstFOR — 4 of 5 Equitable fundsAgainstElected, 95.9% support
Gogo Inc.2026-05-28Advisory vote approving executive compensationAgainstFOR — 4 of 5 Equitable fundsAgainstApproved, 91.9% support
Avadel Pharmaceuticals plc2026-01-12Ordinary resolution to approve any motion by the Chair to adjourn the Extraordinary General Meeting, or any adjournments thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the Extraordinary General Meeting to apAbstainFOR — 4 of 5 Equitable fundsAgainst—
Avadel Pharmaceuticals plc2026-01-12Ordinary resolution to approve the Scheme and authorize the directors of Avadel Pharmaceuticals plc ("Avadel") to take all such actions as they consider necessary or appropriate for carrying the Scheme into effect.AbstainFOR — 4 of 5 Equitable fundsAgainst—
Avadel Pharmaceuticals plc2026-01-12Ordinary resolution to approve, on a non-binding, advisory basis, specified compensatory arrangements between Avadel and its named executive officers relating to the Transaction.AgainstFOR — 4 of 5 Equitable fundsAgainstApproved, 86.4% support
Avadel Pharmaceuticals plc2026-01-12Special resolution to approve an amendment to the Articles of Association of Avadel so that any Avadel Shares that are issued on or after the Voting Record Time to persons other than Alkermes plc or its nominee(s) will either be subject to the Scheme or will be immediately and automatically acquiredAbstainFOR — 4 of 5 Equitable fundsAgainst—
Avadel Pharmaceuticals Plc2026-01-12That the Scheme in its original form or with or subject to any modification(s), addition(s) or condition(s) approved or imposed by the Irish High Court be agreed to.AbstainFOR — 4 of 5 Equitable fundsAgainst—
Avadel Pharmaceuticals Plc2026-01-12That, any motion by the Chair to adjourn the Scheme Meeting, or any adjournments thereof, to another time and place if necessary or appropriate to solicit additional proxies if there are insufficient votes at the time of the Scheme Meeting to approve the Scheme, be approved.AbstainFOR — 4 of 5 Equitable fundsAgainst—
CECO Environmental Corp.2026-05-27Adjournment Proposal. To vote on a proposal to adjourn the CECO annual meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes to approve the CECO stock issuance proposal at the time of the CECO annual meeting (the "CECO adjournment proposal").AbstainFOR — 4 of 5 Equitable fundsAgainst—
CECO Environmental Corp.2026-05-27CECO Director Election Proposal. To vote on a proposal to elect the eight directors named in the accompanying joint proxy statement/prospectus to serve until the next annual meeting of stockholders and until their successors have been duly elected and qualified (the "CECO director election proposal"AgainstFOR — 4 of 5 Equitable fundsAgainstElected, 99.6% support
CECO Environmental Corp.2026-05-27CECO Stock Issuance Proposal. To vote on a proposal to approve the issuance of shares of CECO's common stock, par value $0.01 per share ("CECO common stock"), constituting the stock consideration to be issued to stockholders of Thermon Group Holdings, Inc. ("Thermon") in the first merger contemplateAbstainFOR — 4 of 5 Equitable fundsAgainst—
CSG Systems International, Inc.2026-01-30To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to named executive officers of CSG in connection with the consummation of the merger; andForAGAINST — 4 of 5 Equitable fundsForPassed (calculated), 68.9% support
Global Business Travel Group, Inc.2026-05-13Approval of the amendment to the Company's 2022 Equity Incentive Plan.AgainstFOR — 4 of 5 Equitable fundsAgainstApproved, 97.7% support
Global Business Travel Group, Inc.2026-05-13Election of three Class I directors: Eric HartAgainstFOR — 4 of 5 Equitable fundsAgainstElected, 99.2% support
Global Business Travel Group, Inc.2026-05-13Election of three Class I directors: Kathleen WintersAgainstFOR — 4 of 5 Equitable fundsAgainstElected, 99.1% support
PagSeguro Digital Ltd.2026-05-27Accept Financial Statements and Statutory ReportsForABSTAIN — 4 of 5 Equitable fundsFor—
PagSeguro Digital Ltd.2026-05-27Elect Director Alexandre MagnaniAgainstFOR — 4 of 5 Equitable fundsAgainst—
PagSeguro Digital Ltd.2026-05-27Elect Director Artur Gaulke SchunckAgainstFOR — 4 of 5 Equitable fundsAgainst—
PagSeguro Digital Ltd.2026-05-27Elect Director Cleveland Prates TeixeiraAgainstFOR — 4 of 5 Equitable fundsAgainst—
PagSeguro Digital Ltd.2026-05-27Elect Director Eduardo AlcaroAgainstFOR — 4 of 5 Equitable fundsAgainst—
PagSeguro Digital Ltd.2026-05-27Elect Director Marcia Nogueira de MelloAgainstFOR — 4 of 5 Equitable fundsAgainst—
PagSeguro Digital Ltd.2026-05-27Elect Director Maria Carolina Ferreira LacerdaAgainstFOR — 4 of 5 Equitable fundsAgainst—
PagSeguro Digital Ltd.2026-05-27Elect Director Maria Judith de BritoAgainstFOR — 4 of 5 Equitable fundsAgainst—
Paysign, Inc.2026-05-08Election of Directors: Bruce A. MinaWithholdFOR — 4 of 5 Equitable fundsAgainst—
Paysign, Inc.2026-05-08Election of Directors: Daniel R. HenryWithholdFOR — 4 of 5 Equitable fundsAgainst—
Paysign, Inc.2026-05-08Election of Directors: Jeffrey B. NewmanWithholdFOR — 4 of 5 Equitable fundsAgainst—
Paysign, Inc.2026-05-08Election of Directors: Joan M. HermanWithholdFOR — 4 of 5 Equitable fundsAgainst—
Paysign, Inc.2026-05-08Election of Directors: Matthew LanfordWithholdFOR — 4 of 5 Equitable fundsAgainst—
Supernus Pharmaceuticals, Inc.2026-06-18to elect two (2) directors to hold office for the ensuing three years and until their successors have been duly elected and qualified: Charles W. Newhall, IIIWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 88.4% support
Supernus Pharmaceuticals, Inc.2026-06-18to elect two (2) directors to hold office for the ensuing three years and until their successors have been duly elected and qualified: Frederick M. HudsonWithholdFOR — 4 of 5 Equitable fundsAgainstPassed (calculated), 95.4% support
ThredUp Inc.2026-05-20To elect three Class II directors to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Dan NovaWithholdFOR — 4 of 5 Equitable fundsAgainst—
WK Kellogg Co.2025-09-19The Merger Proposal - To adopt and approve the Agreement and Plan of Merger, dated as of July 10, 2025 (as it may be amended, supplemented or otherwise modified in accordance with its terms, the "Merger Agreement") by and among WK Kellogg Co, a Delaware corporation ("WK Kellog"), Ferrero InternationAbstainFOR — 4 of 5 Equitable fundsAgainstApproved, 93.5% support
Meta Platforms, Inc.2026-05-27Election of Directors: Tony XuWithholdFOR — 13 of 23 Equitable fundsAgainstElected, 91.2% support
The Coca-Cola Company2026-04-29Shareholder Vote on a shareowner proposal requesting a report on the Company's plans to increase sustainability disclosureForAGAINST — 12 of 21 Equitable fundsAgainstFailed (calculated), 22.3% support
QUALCOMM Incorporated2026-03-17Shareholder Stockholder proposal entitled "Shareholder Ability to Call for a Special Meeting."ForAGAINST — 12 of 21 Equitable fundsAgainstNot approved, 42.2% support
PepsiCo, Inc.2026-05-06Shareholder Shareholder Proposal - Report on Human Rights Oversight.ForAGAINST — 11 of 19 Equitable fundsAgainstNot approved, 16.5% support
Vertex Pharmaceuticals Incorporated2026-05-13Shareholder Shareholder proposal, if properly presented at the meeting, regarding shareholder right to act by written consent.ForAGAINST — 10 of 17 Equitable fundsAgainstApproved, 57.0% support
Adobe Inc.2026-04-15Approve, on an advisory basis, the compensation of our named executive officers.AgainstFOR — 10 of 17 Equitable fundsAgainstApproved, 50.7% support
Adobe Inc.2026-04-15Election of the eleven (11) Directors proposed in the accompanying Proxy Statement to serve for a one-year term: Amy BanseAgainstFOR — 10 of 17 Equitable fundsAgainstPassed (calculated), 85.5% support
KKR & Co. Inc.2026-05-21An amendment to the Existing Charter to grant the Board the sole authority to fill board vacancies and newly created directorships.AgainstFOR — 10 of 17 Equitable fundsAgainst—
Carvana Co.2026-05-05Election of Directors: Michael MarooneWithholdFOR — 9 of 15 Equitable fundsAgainstElected, 97.5% support
Ares Management Corporation2026-06-08Election of Directors: Antoinette BushAgainstFOR — 10 of 17 Equitable fundsAgainstElected, 94.3% support
Live Nation Entertainment, Inc.2026-06-11To elect the twelve director nominees identified in the accompanying proxy statement to hold office until the 2027 Annual Meeting of Stockholders: Maverick CarterAgainstFOR — 10 of 17 Equitable fundsAgainstElected, 89.2% support
Texas Pacific Land Corporation2025-11-06To elect the nine directors named in the Proxy Statement to serve until the 2026 Annual Meeting of Stockholders: Murray StahlAgainstFOR — 10 of 17 Equitable fundsAgainstPassed (calculated), 95.8% support
Insulet Corporation2026-05-20Election of Directors: Luciana BorioWithholdFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 93.5% support
Insulet Corporation2026-05-20Election of Directors: Michael R. MinogueWithholdFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 91.1% support
Insulet Corporation2026-05-20Election of Directors: Timothy C. StonesiferWithholdFOR — 9 of 15 Equitable fundsAgainstPassed (calculated), 95.4% support
PACS Group, Inc.2025-12-19To elect Taylor Leavitt and Jacqueline Millard as Class I directors to serve until the 2028 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified: Jacqueline MillardWithholdFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 97.0% support
PACS Group, Inc.2025-12-19To elect Taylor Leavitt and Jacqueline Millard as Class I directors to serve until the 2028 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified: Taylor LeavittWithholdFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 97.0% support
10x Genomics, Inc.2026-06-04Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualificatioAgainstFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 91.3% support
10x Genomics, Inc.2026-06-04Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualificatioAgainstFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 90.7% support
Compass, Inc.2026-05-14Election of Class II Directors: Allan LeinwandAgainstFOR — 5 of 7 Equitable fundsAgainstElected, 97.0% support
Compass, Inc.2026-05-14Election of Class II Directors: Charles PhillipsAgainstFOR — 5 of 7 Equitable fundsAgainstElected, 86.3% support
Compass, Inc.2026-05-14Election of Class II Directors: Pamela Thomas-GrahamAgainstFOR — 5 of 7 Equitable fundsAgainstElected, 96.7% support
Scholar Rock Holding Corporation2026-06-04To elect four Class II directors to our Board of Directors, each to serve until the 2029 Annual Meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, or removal: Katie PengWithholdFOR — 5 of 7 Equitable fundsAgainstElected, 86.8% support
PTC Therapeutics, Inc.2026-06-02Election of Four Class I Directors: Jerome B. Zeldis, M.D., Ph.D.WithholdFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 96.1% support
PTC Therapeutics, Inc.2026-06-02Election of Four Class I Directors: Stephanie S. Okey, M.S.WithholdFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 94.8% support
Red Rock Resorts, Inc.2026-06-04Election of 5 director nominees: Frank J. Fertitta IIIWithholdFOR — 5 of 7 Equitable fundsAgainstElected, 98.8% support
Red Rock Resorts, Inc.2026-06-04Election of 5 director nominees: Lorenzo J. FertittaWithholdFOR — 5 of 7 Equitable fundsAgainstElected, 98.2% support
AAR Corp.2025-09-16Election of four directors named in the proxy statement: Ellen M. LordAgainstFOR — 5 of 7 Equitable fundsAgainstElected, 93.7% support
AAR Corp.2025-09-16Election of four directors named in the proxy statement: Jeffrey N. EdwardsAgainstFOR — 5 of 7 Equitable fundsAgainstElected, 82.1% support
AAR Corp.2025-09-16Election of four directors named in the proxy statement: Marc J. WalfishAgainstFOR — 5 of 7 Equitable fundsAgainstElected, 90.9% support
Lumen Technologies, Inc.2026-05-20Shareholder Approval of a shareholder proposal regarding a shareholder right to vote for or against a poison pill.ForAGAINST — 5 of 7 Equitable fundsAgainstNot approved, 47.8% support
Cabot Corporation2026-03-12Election of Directors: Raffiq NathooAgainstFOR — 5 of 7 Equitable fundsAgainstElected, 96.9% support
Cabot Corporation2026-03-12Election of Directors: Sean D. KeohaneAgainstFOR — 5 of 7 Equitable fundsAgainstElected, 98.8% support
Cabot Corporation2026-03-12Election of Directors: Thierry VanlanckerAgainstFOR — 5 of 7 Equitable fundsAgainstElected, 94.6% support
Wesbanco, Inc.2026-04-15To approve an advisory (non-binding) vote on compensation paid to Wesbanco's named executive officers in 2025.AgainstFOR — 5 of 7 Equitable fundsAgainstApproved, 64.6% support
Oklo Inc.2026-06-03Election of Directors: Richard W. KinzleyWithholdFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 83.3% support
Dyne Therapeutics, Inc.2026-06-05To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: David LubnerWithholdFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 91.5% support
Dyne Therapeutics, Inc.2026-06-05To elect three Class III directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified: Jason RhodesWithholdFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 87.4% support
Celcuity Inc.2026-05-14Elect eight directors: Polly A. MurphyWithholdFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 91.1% support
Celcuity Inc.2026-05-14Elect eight directors: Richard E. BullerWithholdFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 90.3% support
Bank of Hawaii Corporation2026-04-24Say on Pay - An advisory vote on executive compensation.AgainstFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 59.8% support
nLIGHT, Inc.2026-06-05Election of Class II Director: Geoffrey MooreWithholdFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 55.6% support
Stoke Therapeutics, Inc.2026-06-03Election of Class I Directors to serve until the 2029 annual meeting of stockholders or until their successor has been duly elected and qualified or until their earlier resignation or removal: Julie Anne SmithWithholdFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 86.9% support
Stoke Therapeutics, Inc.2026-06-03To approve, on an advisory basis, the compensation of the Company's named executive officers.AgainstFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 72.9% support
CommScope Holding Company, Inc.2025-10-16A proposal to adjourn or postpone the Special Meeting, if necessary or appropriate, for the purpose of soliciting additional votes for the approval of the CCS Sale Proposal (the "Adjournment Proposal").AbstainFOR — 5 of 7 Equitable fundsAgainst—
CommScope Holding Company, Inc.2025-10-16A proposal to adopt the Purchase Agreement and approve the transactions contemplated thereby, including the CCS Sale Transaction (the "CCS Sale Proposal").AbstainFOR — 5 of 7 Equitable fundsAgainstPassed (calculated), 100.0% support
Aeva Technologies, Inc.2026-06-18Election of Class II Directors: Stephen ZadeskyWithholdFOR — 5 of 7 Equitable fundsAgainst—
Texas Capital Bancshares, Inc.2026-04-21To adjourn the Annual Meeting to a later date or dates, if necessary, to solicit additional proxies if there are insufficient votes to adopt any of Proposals 2-5; andAgainstFOR — 5 of 7 Equitable fundsAgainstNot approved, 31.1% support
Texas Capital Bancshares, Inc.2026-04-21To approve the redomestication of the Company from Delaware to Texas by way of conversion;AgainstFOR — 5 of 7 Equitable fundsAgainstNot approved, 45.2% support
Texas Capital Bancshares, Inc.2026-04-21To elect ten (10) directors - each to serve until the next annual meeting of stockholders or until their successors are elected and qualified: Thomas E. LongWithholdFOR — 5 of 7 Equitable fundsAgainstElected, 85.7% support
Meta Platforms, Inc.2026-05-27Election of Directors: Andrew W. HoustonWithholdFOR — 13 of 24 Equitable fundsAgainstElected, 91.1% support
Marsh & McLennan Companies, Inc.2026-05-21Advisory (Nonbinding) Vote to Approve Named Executive Officer CompensationAgainstFOR — 12 of 22 Equitable fundsAgainstApproved, 88.5% support
Chart Industries, Inc.2025-10-06To approve, by a non-binding advisory vote, certain compensation that may be paid or become payable to Chart's named executive officers that is based on or otherwise relates to the Merger.AgainstFOR — 6 of 9 Equitable fundsAgainstApproved, 95.2% support
International Bancshares Corporation2026-05-18ELECTION OF DIRECTORS: A. R. Sanchez, Jr.ForAGAINST — 6 of 9 Equitable fundsForElected, 85.9% support
Caterpillar, Inc.2026-06-10Shareholder Shareholder Proposal - Shareholder Right to Act by Written ConsentForAGAINST — 11 of 20 Equitable fundsAgainstNot approved, 39.5% support
Lam Research Corporation2025-11-04Shareholder Stockholder proposal titled "Realistic Shareholder Ability to Call for a Special Shareholder Meeting," if properly presented.ForAGAINST — 11 of 20 Equitable fundsAgainst—
Arista Networks, Inc.2026-05-29Election of Directors: Greg LavenderWithholdFOR — 10 of 18 Equitable fundsAgainstElected, 79.1% support
Arista Networks, Inc.2026-05-29Election of Directors: Lewis ChewWithholdFOR — 10 of 18 Equitable fundsAgainstElected, 78.3% support
McDonald's Corporation2026-05-20Shareholder Advisory Vote on Shareholders' Right to Act by Written Consent.ForAGAINST — 11 of 20 Equitable fundsAgainstFailed (calculated), 41.9% support
Simon Property Group, Inc.2026-05-13Election of Directors: Daniel C. Smith, Ph.D.AgainstFOR — 11 of 20 Equitable fundsAgainstElected, 95.4% support
Simon Property Group, Inc.2026-05-13Election of Directors: Gary M. RodkinAgainstFOR — 11 of 20 Equitable fundsAgainstElected, 96.3% support
Simon Property Group, Inc.2026-05-13Election of Directors: Glyn F. AeppelAgainstFOR — 11 of 20 Equitable fundsAgainstElected, 87.8% support
Simon Property Group, Inc.2026-05-13Election of Directors: Larry C. GlasscockAgainstFOR — 11 of 20 Equitable fundsAgainstElected, 92.3% support
Simon Property Group, Inc.2026-05-13Election of Directors: Marta R. StewartAgainstFOR — 11 of 20 Equitable fundsAgainstElected, 98.7% support
Simon Property Group, Inc.2026-05-13Election of Directors: Nina P. JonesAgainstFOR — 11 of 20 Equitable fundsAgainstElected, 99.2% support
Simon Property Group, Inc.2026-05-13Election of Directors: Peggy Fang RoeAgainstFOR — 11 of 20 Equitable fundsAgainstElected, 96.6% support
Simon Property Group, Inc.2026-05-13Election of Directors: Randall J. LewisAgainstFOR — 11 of 20 Equitable fundsAgainstElected, 99.2% support
Simon Property Group, Inc.2026-05-13Election of Directors: Reuben S. LeibowitzAgainstFOR — 11 of 20 Equitable fundsAgainstElected, 91.0% support
Simon Property Group, Inc.2026-05-13Election of Directors: Stefan M. SeligAgainstFOR — 11 of 20 Equitable fundsAgainstElected, 98.4% support
Block, Inc.2026-06-16TO ELECT FOUR CLASS II DIRECTORS TO SERVE UNTIL OUR 2029 ANNUAL MEETING OF STOCKHOLDERS AND UNTIL THEIR SUCCESSORS ARE DULY ELECTED AND QUALIFIED: JAMES MCKELVEYWithholdFOR — 10 of 18 Equitable fundsAgainstElected, 93.8% support
Block, Inc.2026-06-16TO ELECT FOUR CLASS II DIRECTORS TO SERVE UNTIL OUR 2029 ANNUAL MEETING OF STOCKHOLDERS AND UNTIL THEIR SUCCESSORS ARE DULY ELECTED AND QUALIFIED: SHAWN CARTERWithholdFOR — 10 of 18 Equitable fundsAgainstElected, 92.4% support
Rockwell Automation, Inc.2026-02-10To elect as directors of Rockwell Automation, Inc. the nominees listed below: Pam MurphyWithholdFOR — 11 of 20 Equitable fundsAgainstElected, 91.6% support
Rockwell Automation, Inc.2026-02-10To elect as directors of Rockwell Automation, Inc. the nominees listed below: Robert W. SoderberyWithholdFOR — 11 of 20 Equitable fundsAgainstElected, 95.4% support
The Hershey Company2026-05-05Election of Directors: Barry J. NalebuffAgainstFOR — 10 of 18 Equitable fundsAgainstPassed (calculated), 99.8% support
The Hershey Company2026-05-05Election of Directors: Cordel Robbin-CokerAgainstFOR — 10 of 18 Equitable fundsAgainstPassed (calculated), 99.6% support
The Hershey Company2026-05-05Election of Directors: Kevin M. OzanAgainstFOR — 10 of 18 Equitable fundsAgainstPassed (calculated), 99.8% support
The Hershey Company2026-05-05Election of Directors: Marie Quintero-JohnsonAgainstFOR — 10 of 18 Equitable fundsAgainstPassed (calculated), 99.8% support
Paycom Software, Inc.2026-05-04To elect two Class I directors, each to serve until the date of the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or his or her earlier death, resignation or removal: J.C. Watts, Jr.AgainstFOR — 10 of 18 Equitable fundsAgainstPassed (calculated), 74.2% support
Paycom Software, Inc.2026-05-04To elect two Class I directors, each to serve until the date of the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or his or her earlier death, resignation or removal: Sharen J. TurneyAgainstFOR — 10 of 18 Equitable fundsAgainstPassed (calculated), 63.5% support
Domino's Pizza, Inc.2026-04-21Shareholder Shareholder proposal regarding an independent board chair requirement.ForAGAINST — 11 of 20 Equitable fundsAgainstNot approved, 39.9% support
Alphabet Inc.2026-06-05Election of ten directors: John L. HennessyAgainstFOR — 13 of 25 Equitable fundsAgainstElected, 85.2% support
Airbnb, Inc.2026-06-05To elect Nathan Blecharczyk, Alfred Lin and James Manyika as Class III Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors are duly elected and qualified: Alfred LinWithholdFOR — 9 of 16 Equitable fundsAgainstPassed (calculated), 97.3% support
Airbnb, Inc.2026-06-05To elect Nathan Blecharczyk, Alfred Lin and James Manyika as Class III Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors are duly elected and qualified: James ManyikaWithholdFOR — 9 of 16 Equitable fundsAgainstPassed (calculated), 98.3% support
Airbnb, Inc.2026-06-05To elect Nathan Blecharczyk, Alfred Lin and James Manyika as Class III Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors are duly elected and qualified: Nathan BlecharczykWithholdFOR — 9 of 16 Equitable fundsAgainstPassed (calculated), 98.5% support
Fortinet, Inc.2026-06-12To elect nine directors to serve for a term of one year until the next annual meeting of stockholders or until their respective successors have been duly elected and qualified: Kenneth A. GoldmanAgainstFOR — 9 of 16 Equitable fundsAgainstPassed (calculated), 84.6% support
IDEXX Laboratories, Inc.2026-05-12Shareholder Shareholder Proposal to Give Shareholders the Ability to Call for a Special Shareholder Meeting (Proposal Six).ForAGAINST — 9 of 16 Equitable fundsAgainst—
Expedia Group, Inc.2026-06-17Election of Directors: Alex von FurstenbergWithholdFOR — 9 of 16 Equitable fundsAgainstPassed (calculated), 92.9% support
Expedia Group, Inc.2026-06-17Election of Directors: Barry DillerWithholdFOR — 9 of 16 Equitable fundsAgainstPassed (calculated), 80.2% support
Expedia Group, Inc.2026-06-17Election of Directors: Beverly AndersonWithholdFOR — 9 of 16 Equitable fundsAgainstPassed (calculated), 99.0% support
Expedia Group, Inc.2026-06-17Election of Directors: Chelsea ClintonWithholdFOR — 9 of 16 Equitable fundsAgainstPassed (calculated), 96.7% support
Expedia Group, Inc.2026-06-17Election of Directors: Henrique Dubugras*WithholdFOR — 9 of 16 Equitable fundsAgainstPassed (calculated), 98.8% support
Expedia Group, Inc.2026-06-17Election of Directors: M. Moina Banerjee*WithholdFOR — 9 of 16 Equitable fundsAgainstPassed (calculated), 98.4% support
Expedia Group, Inc.2026-06-17Election of Directors: Patricia Menendez Cambo*WithholdFOR — 9 of 16 Equitable fundsAgainstPassed (calculated), 98.8% support
The Trade Desk, Inc.2026-05-04The election of two Class I directors to hold office until our 2029 annual meeting of stockholders or until his or her successor is duly elected and qualified: Jeff T. GreenWithholdFOR — 8 of 14 Equitable fundsAgainstPassed (calculated), 92.5% support
Fastenal Company2026-04-23Shareholder Shareholder proposal relating to an EEO-1 reporting disclosure policy, if properly presented at the annual meeting.ForAGAINST or ABSTAIN — 11 of 21 Equitable funds—Not approved, 23.0% support
CBRE Group, Inc.2026-05-21Shareholder Stockholder proposal regarding our stockholders' ability to call special stockholder meetings.ForAGAINST — 10 of 19 Equitable fundsAgainst—
Steel Dynamics, Inc.2026-05-06Shareholder SHAREHOLDER PROPOSAL - AVOID POLITICAL SPENDING BRAND DAMAGEForAGAINST — 10 of 19 Equitable fundsAgainstFailed (calculated), 39.3% support
Verisk Analytics, Inc.2026-05-19Shareholder Shareholder Proposal - Shareholder Right to Act by Written Consent.ForAGAINST — 10 of 19 Equitable fundsAgainstApproved, 53.3% support
UDR, Inc.2026-05-21ELECTION OF DIRECTORS: Jon A. GroveAgainstFOR — 10 of 19 Equitable fundsAgainstElected, 92.1% support
UDR, Inc.2026-05-21ELECTION OF DIRECTORS: Mark R. PattersonAgainstFOR — 10 of 19 Equitable fundsAgainstElected, 92.4% support
UDR, Inc.2026-05-21ELECTION OF DIRECTORS: Mary Ann KingAgainstFOR — 10 of 19 Equitable fundsAgainstElected, 93.3% support
UDR, Inc.2026-05-21ELECTION OF DIRECTORS: Robert A. McNamaraAgainstFOR — 10 of 19 Equitable fundsAgainstElected, 89.3% support
The Goldman Sachs Group, Inc.2026-04-29Shareholder Shareholder Proposal Regarding Disclosure of Energy Supply RatioForAGAINST — 9 of 17 Equitable fundsAgainstNot approved, 18.4% support
The Goldman Sachs Group, Inc.2026-04-29Shareholder Shareholder Proposal Regarding Special Shareholder Meeting ThresholdsForAGAINST — 9 of 17 Equitable fundsAgainstFailed (calculated), 36.9% support
Lockheed Martin Corporation2026-05-12Election of Nine Directors: Thomas J. FalkAgainstFOR — 9 of 17 Equitable fundsAgainstPassed (calculated), 88.7% support
KKR & Co. Inc.2026-05-21Other amendments to the Existing Charter to modernize and streamline the Existing Charter.AgainstFOR — 9 of 17 Equitable fundsAgainst—
Robinhood Markets, Inc.2026-06-02To elect to the Board of Directors the ten director nominees named in the proxy statement: Baiju BhattAgainstFOR — 9 of 17 Equitable fundsAgainstPassed (calculated), 99.7% support
Robinhood Markets, Inc.2026-06-02To elect to the Board of Directors the ten director nominees named in the proxy statement: Christopher PayneAgainstFOR — 9 of 17 Equitable fundsAgainstPassed (calculated), 99.7% support
Robinhood Markets, Inc.2026-06-02To elect to the Board of Directors the ten director nominees named in the proxy statement: Dara TresederAgainstFOR — 9 of 17 Equitable fundsAgainstPassed (calculated), 95.0% support
Robinhood Markets, Inc.2026-06-02To elect to the Board of Directors the ten director nominees named in the proxy statement: John HegemanAgainstFOR — 9 of 17 Equitable fundsAgainstPassed (calculated), 99.7% support
Robinhood Markets, Inc.2026-06-02To elect to the Board of Directors the ten director nominees named in the proxy statement: Jonathan RubinsteinAgainstFOR — 9 of 17 Equitable fundsAgainstPassed (calculated), 90.7% support
Robinhood Markets, Inc.2026-06-02To elect to the Board of Directors the ten director nominees named in the proxy statement: Meyer MalkaAgainstFOR — 9 of 17 Equitable fundsAgainstPassed (calculated), 99.7% support
Robinhood Markets, Inc.2026-06-02To elect to the Board of Directors the ten director nominees named in the proxy statement: Paula LoopAgainstFOR — 9 of 17 Equitable fundsAgainstPassed (calculated), 99.6% support
Robinhood Markets, Inc.2026-06-02To elect to the Board of Directors the ten director nominees named in the proxy statement: Robert ZoellickAgainstFOR — 9 of 17 Equitable fundsAgainstPassed (calculated), 95.0% support
Robinhood Markets, Inc.2026-06-02To elect to the Board of Directors the ten director nominees named in the proxy statement: Susan SegalAgainstFOR — 9 of 17 Equitable fundsAgainstPassed (calculated), 99.1% support
Robinhood Markets, Inc.2026-06-02To elect to the Board of Directors the ten director nominees named in the proxy statement: Vladimir TenevAgainstFOR — 9 of 17 Equitable fundsAgainstPassed (calculated), 98.9% support
Apollo Global Management, Inc.2026-06-08The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Brian LeachAgainstFOR — 9 of 17 Equitable fundsAgainstElected, 99.1% support
Apollo Global Management, Inc.2026-06-08The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Gary CohnAgainstFOR — 9 of 17 Equitable fundsAgainstElected, 97.0% support
Apollo Global Management, Inc.2026-06-08The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: James BelardiAgainstFOR — 9 of 17 Equitable fundsAgainstElected, 99.6% support
Apollo Global Management, Inc.2026-06-08The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: James ZelterAgainstFOR — 9 of 17 Equitable fundsAgainstElected, 99.6% support
Apollo Global Management, Inc.2026-06-08The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Jessica BibliowiczAgainstFOR — 9 of 17 Equitable fundsAgainstElected, 99.5% support
Apollo Global Management, Inc.2026-06-08The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Kerry Murphy HealeyAgainstFOR — 9 of 17 Equitable fundsAgainstElected, 99.3% support
Apollo Global Management, Inc.2026-06-08The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Lynn SwannAgainstFOR — 9 of 17 Equitable fundsAgainstElected, 98.3% support
Apollo Global Management, Inc.2026-06-08The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Marc BeilinsonAgainstFOR — 9 of 17 Equitable fundsAgainstElected, 96.9% support
Apollo Global Management, Inc.2026-06-08The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Marc RowanAgainstFOR — 9 of 17 Equitable fundsAgainstElected, 98.3% support
Apollo Global Management, Inc.2026-06-08The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Mitra HormoziAgainstFOR — 9 of 17 Equitable fundsAgainstElected, 98.4% support
Apollo Global Management, Inc.2026-06-08The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Pamela JoynerAgainstFOR — 9 of 17 Equitable fundsAgainstElected, 99.3% support
Apollo Global Management, Inc.2026-06-08The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Patrick ToomeyAgainstFOR — 9 of 17 Equitable fundsAgainstElected, 99.5% support
Apollo Global Management, Inc.2026-06-08The election of the following directors to the board of directors for a one-year term to expire at the annual meeting of stockholders of AGM to be held in 2027: Scott KleinmanAgainstFOR — 9 of 17 Equitable fundsAgainstElected, 99.6% support
Atlassian Corporation2025-12-02Election of Directors: Michelle ZatlynAgainstFOR — 5 of 8 Equitable fundsAgainstPassed (calculated), 99.9% support
Atlassian Corporation2025-12-02Election of Directors: Sasan GoodarziAgainstFOR — 5 of 8 Equitable fundsAgainstPassed (calculated), 99.5% support
Atlassian Corporation2025-12-02Election of Directors: Scott BelskyAgainstFOR — 5 of 8 Equitable fundsAgainstPassed (calculated), 99.9% support
Atlassian Corporation2025-12-02Election of Directors: Scott FarquharAgainstFOR — 5 of 8 Equitable fundsAgainstPassed (calculated), 96.9% support
Atlassian Corporation2025-12-02Election of Directors: Steven SordelloAgainstFOR — 5 of 8 Equitable fundsAgainstPassed (calculated), 99.8% support
Coinbase Global, Inc.2026-06-16Election of Directors: Brian ArmstrongWithholdFOR — 9 of 17 Equitable fundsAgainstElected, 97.9% support
Coinbase Global, Inc.2026-06-16Election of Directors: Chris LehaneWithholdFOR — 9 of 17 Equitable fundsAgainstElected, 99.8% support
Coinbase Global, Inc.2026-06-16Election of Directors: Christa DaviesWithholdFOR — 9 of 17 Equitable fundsAgainstElected, 99.9% support
Coinbase Global, Inc.2026-06-16Election of Directors: Fred WilsonWithholdFOR — 9 of 17 Equitable fundsAgainstElected, 99.3% support
Coinbase Global, Inc.2026-06-16Election of Directors: Gokul RajaramWithholdFOR — 9 of 17 Equitable fundsAgainstElected, 96.1% support
Coinbase Global, Inc.2026-06-16Election of Directors: Kelly A. KramerWithholdFOR — 9 of 17 Equitable fundsAgainstElected, 99.4% support
Coinbase Global, Inc.2026-06-16Election of Directors: Marc L. AndreessenWithholdFOR — 9 of 17 Equitable fundsAgainstElected, 97.1% support
Coinbase Global, Inc.2026-06-16Election of Directors: Tobias LutkeWithholdFOR — 9 of 17 Equitable fundsAgainstElected, 99.7% support
Roblox Corporation2026-05-28Election of Class II Directors: Gregory BaszuckiWithholdFOR — 5 of 8 Equitable fundsAgainstElected, 93.7% support
Affirm Holdings, Inc.2025-12-15To elect the three Class II nominees for director named in the accompanying proxy statement to hold office until the 2028 Annual Meeting and until their successors have been duly elected and qualified or until such director's earlier death, resignation or removal: Christa S. QuarlesForAGAINST — 5 of 8 Equitable fundsAgainstElected, 96.0% support
Lamar Advertising Company2026-05-14Election of directors: Anna ReillyWithholdFOR — 5 of 8 Equitable fundsAgainstElected, 92.4% support
Lamar Advertising Company2026-05-14Election of directors: Elizabeth ThompsonWithholdFOR — 5 of 8 Equitable fundsAgainstElected, 92.6% support
Lamar Advertising Company2026-05-14Election of directors: Kevin P. Reilly, Jr.WithholdFOR — 5 of 8 Equitable fundsAgainstElected, 92.3% support
Lamar Advertising Company2026-05-14Election of directors: Marshall A. LoebWithholdFOR — 5 of 8 Equitable fundsAgainstElected, 91.4% support
Lamar Advertising Company2026-05-14Election of directors: Mitch LandrieuWithholdFOR — 5 of 8 Equitable fundsAgainstElected, 99.8% support
Lamar Advertising Company2026-05-14Election of directors: Nancy FletcherWithholdFOR — 5 of 8 Equitable fundsAgainstElected, 99.6% support
Lamar Advertising Company2026-05-14Election of directors: Thomas V. ReifenheiserWithholdFOR — 5 of 8 Equitable fundsAgainstElected, 89.9% support
Lamar Advertising Company2026-05-14Election of directors: Wendell ReillyWithholdFOR — 5 of 8 Equitable fundsAgainstElected, 92.4% support
Nextracker Inc.2025-08-18The election of each of Nextracker's nominees for director to hold office until the 2028 Annual Meeting of Stockholders: Brandi ThomasWithholdFOR — 5 of 8 Equitable fundsAgainstElected, 96.5% support
Nextracker Inc.2025-08-18The election of each of Nextracker's nominees for director to hold office until the 2028 Annual Meeting of Stockholders: Jeffrey GuldnerWithholdFOR — 5 of 8 Equitable fundsAgainstElected, 74.3% support
BridgeBio Pharma, Inc.2026-06-22To elect three (3) nominees for director, James C. Momtazee, Frank P. McCormick, Ph.D., and Hannah A. Valantine, M.D., to serve as Class I directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2028 and until their successors are duly eleWithholdFOR — 5 of 8 Equitable fundsAgainstPassed (calculated), 97.3% support
BridgeBio Pharma, Inc.2026-06-22To elect three (3) nominees for director, James C. Momtazee, Frank P. McCormick, Ph.D., and Hannah A. Valantine, M.D., to serve as Class I directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2028 and until their successors are duly eleWithholdFOR — 5 of 8 Equitable fundsAgainstPassed (calculated), 95.0% support
BridgeBio Pharma, Inc.2026-06-22To elect three (3) nominees for director, James C. Momtazee, Frank P. McCormick, Ph.D., and Hannah A. Valantine, M.D., to serve as Class I directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2028 and until their successors are duly eleWithholdFOR — 5 of 8 Equitable fundsAgainstPassed (calculated), 80.1% support
Kymera Therapeutics, Inc.2026-06-24To elect four class III directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Elena Ridloff, CFAWithholdFOR — 5 of 8 Equitable fundsAgainstPassed (calculated), 93.6% support
Hecla Mining Company2026-05-21ELECTION OF TWO CLASS I DIRECTORS: Dean R. GehringAgainstFOR — 5 of 8 Equitable fundsAgainstElected, 96.3% support
Granite Construction Incorporated2026-06-04Election of Directors: Carlos M. HernandezAgainstFOR — 5 of 8 Equitable fundsAgainstPassed (calculated), 96.1% support
Granite Construction Incorporated2026-06-04Election of Directors: Celeste B. MastinAgainstFOR — 5 of 8 Equitable fundsAgainstPassed (calculated), 94.6% support
EnerSys2025-07-31Elect three (3) Class III director nominees: Howard I. HoffenAgainstFOR — 5 of 8 Equitable fundsAgainstElected, 86.9% support
EnerSys2025-07-31Elect three (3) Class III director nominees: Ronald P. VargoAgainstFOR — 5 of 8 Equitable fundsAgainstElected, 96.4% support
Itron, Inc.2026-05-07Election of Directors: Frank M. JaehnertAgainstFOR — 5 of 8 Equitable fundsAgainstElected, 83.7% support
Itron, Inc.2026-05-07Election of Directors: Jerome J. LandeAgainstFOR — 5 of 8 Equitable fundsAgainstElected, 96.0% support
Itron, Inc.2026-05-07Election of Directors: Sanjay MirchandaniAgainstFOR — 5 of 8 Equitable fundsAgainstElected, 96.5% support
ICU Medical, Inc.2026-05-13Shareholder To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right.ForAGAINST — 6 of 10 Equitable fundsAgainstNot approved, 40.7% support
Applied Optoelectronics, Inc.2026-06-04Class I Directors for Election: Che-Wei LinWithholdFOR — 5 of 8 Equitable fundsAgainst—
Applied Optoelectronics, Inc.2026-06-04To approve the 2026 equity incentive plan.AgainstFOR — 5 of 8 Equitable fundsAgainstPassed (calculated), 90.2% support
Denali Therapeutics Inc.2026-06-03ELECTION OF DIRECTORS: David Schenkein, M.D.WithholdFOR — 5 of 8 Equitable fundsAgainstElected, 73.5% support
Nuvalent, Inc.2026-06-16Election of the following nominees as Class II directors: Michael L. Meyers, M.D., Ph.D.WithholdFOR — 5 of 8 Equitable fundsAgainstElected, 81.5% support
Carvana Co.2026-05-05Election of Directors: Neha ParikhWithholdFOR — 8 of 15 Equitable fundsAgainstElected, 95.0% support
Rocket Companies, Inc.2026-06-10Election of Class III Directors: Suzanne ShankForWITHHOLD — 3 of 4 Equitable fundsForPassed (calculated), 89.6% support
Astera Labs, Inc.2026-06-04To elect three Class II directors to our board of directors to serve until the 2029 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Craig BarrattForWITHHOLD — 3 of 4 Equitable fundsAgainstElected, 83.8% support
Tradeweb Markets Inc.2026-05-19Election of Directors: Catherine JohnsonForWITHHOLD — 4 of 6 Equitable fundsAgainstElected, 97.4% support
Tradeweb Markets Inc.2026-05-19Election of Directors: Daniel MaguireForWITHHOLD — 4 of 6 Equitable fundsAgainstElected, 97.4% support
Tradeweb Markets Inc.2026-05-19Election of Directors: Scott GanelesForWITHHOLD — 4 of 6 Equitable fundsAgainstElected, 96.9% support
Alnylam Pharmaceuticals, Inc.2026-05-20To elect the following nominees as Class I directors of Alnylam: Yvonne L. Greenstreet, M.D.AgainstFOR — 4 of 6 Equitable fundsAgainstElected, 99.6% support
Life Time Group Holdings, Inc.2026-04-22Election of Class II Directors: J. Kristofer GalashanWithholdFOR — 3 of 4 Equitable fundsAgainstElected, 76.4% support
Life Time Group Holdings, Inc.2026-04-22Election of Class II Directors: Jennifer PomerantzWithholdFOR — 3 of 4 Equitable fundsAgainstElected, 77.4% support
Life Time Group Holdings, Inc.2026-04-22Election of Class II Directors: Joel AlsfineWithholdFOR — 3 of 4 Equitable fundsAgainstElected, 94.8% support
Life Time Group Holdings, Inc.2026-04-22Election of Class II Directors: Jonathan CosletWithholdFOR — 3 of 4 Equitable fundsAgainstElected, 79.6% support
Life Time Group Holdings, Inc.2026-04-22Election of Class II Directors: Stuart LasherWithholdFOR — 3 of 4 Equitable fundsAgainstElected, 89.4% support
Oscar Health, Inc.2026-06-04Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: David Alexander PlouffeWithholdFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 99.5% support
Oscar Health, Inc.2026-06-04Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: Laura LangWithholdFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 99.9% support
Oscar Health, Inc.2026-06-04Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: Siddhartha SankaranWithholdFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 99.7% support
Oscar Health, Inc.2026-06-04Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: Vanessa Ames WittmanWithholdFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 99.8% support
Oscar Health, Inc.2026-06-04Election of eight director nominees to serve until the 2027 Annual Meeting of Stockholders: William (Bill) J. Gassen IIIWithholdFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 96.9% support
TG Therapeutics, Inc.2026-06-11Election of Directors: Laurence CharneyWithholdFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 83.7% support
TG Therapeutics, Inc.2026-06-11Election of Directors: Michael S. WeissWithholdFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 88.6% support
PACS Group, Inc.2026-06-10To elect Evelyn Dilsaver and Mark Hancock as Class II directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors shall have been duly elected and qualified: Evelyn DilsaverWithholdFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 95.0% support
Amneal Pharmaceuticals, Inc.2026-05-06Election of Directors: Paul MeisterAgainstFOR — 4 of 6 Equitable fundsAgainstElected, 87.5% support
Casella Waste Systems, Inc.2026-06-04To elect the following nominees as Class II directors of the Company to serve until the 2029 Annual Meeting of Stockholders: Emily Nagle GreenWithholdFOR — 4 of 6 Equitable fundsAgainstElected, 66.5% support
Casella Waste Systems, Inc.2026-06-04To elect the following nominees as Class II directors of the Company to serve until the 2029 Annual Meeting of Stockholders: Joseph G. DoodyWithholdFOR — 4 of 6 Equitable fundsAgainstElected, 89.9% support
Casella Waste Systems, Inc.2026-06-04To elect the following nominees as Class II directors of the Company to serve until the 2029 Annual Meeting of Stockholders: Michael L. BattlesWithholdFOR — 4 of 6 Equitable fundsAgainstElected, 73.4% support
PJT Partners Inc.2026-06-18To elect the three nominees for Class II directors listed below, each to serve for a three-year term expiring at the 2029 annual meeting of shareholders (Proposal 1): K. Don CornwellWithholdFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 97.8% support
PJT Partners Inc.2026-06-18To elect the three nominees for Class II directors listed below, each to serve for a three-year term expiring at the 2029 annual meeting of shareholders (Proposal 1): Thomas M. RyanWithholdFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 84.6% support
Vicor Corporation2026-06-19To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Andrew T. D'AmicoWithholdFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 94.3% support
Vicor Corporation2026-06-19To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Claudio TuozzoloWithholdFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 94.3% support
Vicor Corporation2026-06-19To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: James F. SchmidtWithholdFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 94.1% support
Vicor Corporation2026-06-19To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Jason L. CarlsonWithholdFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 93.7% support
Vicor Corporation2026-06-19To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: John ShenWithholdFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 94.7% support
Vicor Corporation2026-06-19To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Michael S. McNamaraWithholdFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 94.3% support
Vicor Corporation2026-06-19To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Patrizio VinciarelliWithholdFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 94.0% support
Vicor Corporation2026-06-19To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Philip D. DaviesWithholdFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 94.5% support
Vicor Corporation2026-06-19To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Samuel J. AndersonWithholdFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 94.4% support
Vicor Corporation2026-06-19To fix the number of Directors at eleven and to elect the following eleven nominees as Directors to hold office until the 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified: Zmira LavieWithholdFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 94.7% support
RadNet, Inc.2026-06-02Election of Directors until the next Annual Meeting of Stockholders or until their successors are duly elected and qualified: Laura P. JacobsWithholdFOR — 4 of 6 Equitable fundsAgainstElected, 87.4% support
Balchem Corporation2026-06-18Election of Directors: Daniel KnutsonAgainstFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 98.4% support
Balchem Corporation2026-06-18Election of Directors: David FischerAgainstFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 93.1% support
OUTFRONT Media Inc.2026-06-03Election of Director Nominees: Angela CourtinAgainstFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 76.3% support
OUTFRONT Media Inc.2026-06-03Election of Director Nominees: Manuel A. DiazAgainstFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 99.5% support
OUTFRONT Media Inc.2026-06-03Election of Director Nominees: Mark CarletonAgainstFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 99.7% support
OUTFRONT Media Inc.2026-06-03Election of Director Nominees: Michael J. DominguezAgainstFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 98.7% support
OUTFRONT Media Inc.2026-06-03Election of Director Nominees: Nicolas BrienAgainstFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 99.6% support
OUTFRONT Media Inc.2026-06-03Election of Director Nominees: Peter MathesAgainstFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 98.7% support
OUTFRONT Media Inc.2026-06-03Election of Director Nominees: Susan M. TolsonAgainstFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 66.4% support
Varonis Systems, Inc.2026-06-01To elect four Class III director nominees named herein to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: Avrohom J. KessWithholdFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 91.1% support
Varonis Systems, Inc.2026-06-01To elect four Class III director nominees named herein to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: Thomas F. MendozaWithholdFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 94.4% support
Waystar Holding Corp.2026-06-01Elect the four Class II directors named in our proxy statement to hold office until the 2029 annual meeting of stockholders and until their respective successors have been elected and qualified: John DriscollWithholdFOR — 4 of 6 Equitable fundsAgainstElected, 86.5% support
Concentra Group Holdings Parent, Inc.2026-04-30Elect three Class II directors, each for a term of three years or until their respective successors have been elected and qualified: Marc R. WatkinsAgainstFOR — 4 of 6 Equitable fundsAgainstElected, 81.8% support
Merit Medical Systems, Inc.2026-05-13The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for the term length indicated below or until their successors are elected and qualified: Lonny J. Carpenter (three (3) year term)AgainstFOR — 4 of 6 Equitable fundsAgainstElected, 97.6% support
Merit Medical Systems, Inc.2026-05-13The election of four (4) directors to the Merit Medical Systems, Inc. Board of Directors for the term length indicated below or until their successors are elected and qualified: Lynne N. Ward (one (1) year term)AgainstFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 97.8% support
Joby Aviation, Inc.2026-06-02Election of Directors: To be elected for terms expiring in 2029: Halimah DeLaine PradoWithholdFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 92.9% support
Joby Aviation, Inc.2026-06-02Election of Directors: To be elected for terms expiring in 2029: Laura WrightWithholdFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 98.4% support
Joby Aviation, Inc.2026-06-02Election of Directors: To be elected for terms expiring in 2029: Paul SciarraWithholdFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 98.9% support
Axos Financial, Inc.2025-11-13Election of Directors: James J. CourtWithholdFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 62.4% support
Axos Financial, Inc.2025-11-13Election of Directors: James S. ArgalasWithholdFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 95.7% support
Axos Financial, Inc.2025-11-13Election of Directors: Roque A. SantiWithholdFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 97.1% support
Axos Financial, Inc.2025-11-13Election of Directors: Stefani D. CarterWithholdFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 62.8% support
Axos Financial, Inc.2025-11-13To approve an amendment to the Amended and Restated 2014 Stock Incentive Plan.AgainstFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 63.1% support
Axos Financial, Inc.2025-11-13To approve in a non-binding and advisory vote, the compensation of the Company's Named Executive Officers as disclosed in the proxy statement.AgainstFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 58.7% support
Cavco Industries, Inc.2025-07-29Election of Directors: David A. GreenblattAgainstFOR — 3 of 4 Equitable fundsAgainstElected, 89.9% support
Cavco Industries, Inc.2025-07-29Election of Directors: Julia W. SzeAgainstFOR — 3 of 4 Equitable fundsAgainstElected, 97.1% support
Cavco Industries, Inc.2025-07-29Election of Directors: Richard A. KerleyAgainstFOR — 3 of 4 Equitable fundsAgainstElected, 95.6% support
Travere Therapeutics, Inc.2026-05-19To elect each of the Board's ten nominees for director named in the accompanying proxy statement to serve for a term of one year. ELECTION OF DIRECTORS: Roy BaynesForWITHHOLD — 4 of 6 Equitable fundsForElected, 87.7% support
Cinemark Holdings, Inc.2026-05-144 wordings Election of Class I directors, each for a term that expires in 2029: Nancy LoeweWithholdFOR — 3 of 4 Equitable fundsAgainstElected, 94.3% support
The Baldwin Insurance Group, Inc.2026-06-04Company Proposal - To elect four Class I Directors to serve until the 2029 Annual Meeting of Shareholders or until their successors are duly elected and qualified: Ellyn ShookWithholdFOR — 4 of 6 Equitable fundsAgainstElected, 82.2% support
The Baldwin Insurance Group, Inc.2026-06-04Company Proposal - To elect four Class I Directors to serve until the 2029 Annual Meeting of Shareholders or until their successors are duly elected and qualified: Lowry BaldwinWithholdFOR — 4 of 6 Equitable fundsAgainstElected, 95.7% support
The Baldwin Insurance Group, Inc.2026-06-04Company Proposal - To elect four Class I Directors to serve until the 2029 Annual Meeting of Shareholders or until their successors are duly elected and qualified: Sathish MuthukrishnanWithholdFOR — 4 of 6 Equitable fundsAgainstElected, 99.0% support
The Baldwin Insurance Group, Inc.2026-06-04Company Proposal - To elect four Class I Directors to serve until the 2029 Annual Meeting of Shareholders or until their successors are duly elected and qualified: Sunita ParasuramanWithholdFOR — 4 of 6 Equitable fundsAgainstElected, 98.9% support
Magnite, Inc.2026-06-08Election of Class III Directors: David PearsonAgainstFOR — 3 of 4 Equitable fundsAgainstElected, 95.3% support
Magnite, Inc.2026-06-08Election of Class III Directors: Doug KnopperAgainstFOR — 3 of 4 Equitable fundsAgainstElected, 92.8% support
Magnite, Inc.2026-06-08Election of Class III Directors: Paul CaineAgainstFOR — 3 of 4 Equitable fundsAgainstElected, 95.0% support
First Advantage Corporation2026-06-05To elect three Class II director nominees listed in this Proxy Statement: Bridgett R. PriceWithholdFOR — 4 of 6 Equitable fundsAgainstElected, 93.7% support
Solaris Energy Infrastructure, Inc.2026-05-15Election of Directors: A. James TeagueWithholdFOR — 3 of 4 Equitable fundsAgainstElected, 96.7% support
Solaris Energy Infrastructure, Inc.2026-05-15Election of Directors: Edgar R. GiesingerWithholdFOR — 3 of 4 Equitable fundsAgainstElected, 78.9% support
Solaris Energy Infrastructure, Inc.2026-05-15Election of Directors: William A. ZartlerWithholdFOR — 3 of 4 Equitable fundsAgainstElected, 96.6% support
BancFirst Corporation2026-05-28Election of Directors: David R. HarlowAgainstFOR — 4 of 6 Equitable fundsAgainstElected, 85.0% support
Cohen & Steers, Inc.2026-04-30Election of Directors: Edmond D. VillaniForAGAINST — 4 of 6 Equitable fundsForPassed (calculated), 87.9% support
Wesbanco, Inc.2026-04-15To elect six persons to the Board of Directors. (a) Five to serve for a term of three years, and (b) one to serve for a term of one year. (a) For a term of three (3) years expiring at the annual stockholders meeting in 2029: Denise Knouse-SnyderWithholdFOR — 4 of 6 Equitable fundsAgainstElected, 94.4% support
Wesbanco, Inc.2026-04-15To elect six persons to the Board of Directors. (a) Five to serve for a term of three years, and (b) one to serve for a term of one year. (a) For a term of three (3) years expiring at the annual stockholders meeting in 2029: F. Eric Nelson, Jr.WithholdFOR — 4 of 6 Equitable fundsAgainstElected, 91.3% support
Wesbanco, Inc.2026-04-15To elect six persons to the Board of Directors. (a) Five to serve for a term of three years, and (b) one to serve for a term of one year. (a) For a term of three (3) years expiring at the annual stockholders meeting in 2029: John L. BookmyerWithholdFOR — 4 of 6 Equitable fundsAgainstElected, 97.6% support
Wesbanco, Inc.2026-04-15To elect six persons to the Board of Directors. (a) Five to serve for a term of three years, and (b) one to serve for a term of one year. (a) For a term of three (3) years expiring at the annual stockholders meeting in 2029: Louis M. AltmanWithholdFOR — 4 of 6 Equitable fundsAgainstElected, 97.6% support
Wesbanco, Inc.2026-04-15To elect six persons to the Board of Directors. (a) Five to serve for a term of three years, and (b) one to serve for a term of one year. (a) For a term of three (3) years expiring at the annual stockholders meeting in 2029: Todd F. ClossinWithholdFOR — 4 of 6 Equitable fundsAgainstElected, 97.2% support
Wesbanco, Inc.2026-04-15To elect six persons to the Board of Directors. (a) Five to serve for a term of three years, and (b) one to serve for a term of one year. (b) For a term of one (1) year expiring at the annual stockholders meeting in 2027: Joseph R. RobinsonWithholdFOR — 4 of 6 Equitable fundsAgainstElected, 97.7% support
Core Scientific, Inc.2026-05-12Election of Directors: Elizabeth CrainWithholdFOR — 4 of 6 Equitable fundsAgainstElected, 97.7% support
Core Scientific, Inc.2026-05-12To approve, on a non-binding, advisory basis, the compensation of our named executive officers.AgainstFOR — 4 of 6 Equitable fundsAgainstApproved, 63.7% support
Kadant Inc.2026-05-20Election of two directors to the class to be elected for a three-year term expiring in 2029: John M. AlbertineAgainstFOR — 3 of 4 Equitable fundsAgainst—
Kadant Inc.2026-05-20Election of two directors to the class to be elected for a three-year term expiring in 2029: Thomas C. LeonardAgainstFOR — 3 of 4 Equitable fundsAgainst—
HNI Corporation2025-12-05Proposal to approve the issuance of shares of HNI common stock to holders of Steelcase common stock pursuant to the Merger Agreement (the "HNI common stock issuance proposal").AbstainFOR — 4 of 6 Equitable fundsAgainstApproved, 96.9% support
United States Lime & Minerals, Inc.2026-05-01To approve, on a non-binding advisory basis, the Company's executive compensation.ForAGAINST — 3 of 4 Equitable fundsForApproved, 87.9% support
United States Lime & Minerals, Inc.2026-05-01To elect Directors - Nominees: R. W. CardinForWITHHOLD — 3 of 4 Equitable fundsForElected, 91.0% support
Arcutis Biotherapeutics, Inc.2026-06-052 wordings Election of Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Patrick J. HeronWithholdFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 67.4% support
Oceaneering International, Inc.2026-05-15Election of Class I Directors: Jon Erik ReinhardsenWithholdFOR — 4 of 6 Equitable fundsAgainstElected, 81.0% support
Oceaneering International, Inc.2026-05-15Election of Class I Directors: Reema PoddarWithholdFOR — 4 of 6 Equitable fundsAgainstElected, 91.8% support
Oceaneering International, Inc.2026-05-15Election of Class I Directors: William B. BerryWithholdFOR — 4 of 6 Equitable fundsAgainstElected, 96.9% support
The GEO Group, Inc.2026-04-28Advisory vote to approve named executive officer compensation.ForAGAINST — 3 of 4 Equitable fundsForApproved, 71.6% support
The GEO Group, Inc.2026-04-28Election of Directors: Jack BrewerForAGAINST — 3 of 4 Equitable fundsForElected, 78.5% support
Lemonade, Inc.2026-06-03Election of Class III Directors: Debra SchwartzWithholdFOR — 3 of 4 Equitable fundsAgainstElected, 87.6% support
Group 1 Automotive, Inc.2026-05-12Shareholder Shareholder Proposal: Give Shareholders an Ability to Call for a Special Shareholder Meeting.ForAGAINST — 3 of 4 Equitable fundsAgainstNot approved, 25.3% support
Celcuity Inc.2026-05-14To approve the Celcuity Inc. Amended and Restated Employee Stock Purchase Plan.ForAGAINST — 4 of 6 Equitable fundsFor—
TriNet Group, Inc.2026-05-27Election of Directors: David C. HodgsonWithholdFOR — 3 of 4 Equitable fundsAgainstElected, 96.2% support
TriNet Group, Inc.2026-05-27Election of Directors: Jacqueline KosecoffWithholdFOR — 3 of 4 Equitable fundsAgainstElected, 98.7% support
TriNet Group, Inc.2026-05-27Election of Directors: Michael J. AngelakisWithholdFOR — 3 of 4 Equitable fundsAgainstElected, 97.5% support
Archer Aviation Inc.2026-06-26Approval of the redomestication of the Company from Delaware to Texas by conversion.AgainstFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 84.0% support
Archer Aviation Inc.2026-06-26Approval, on a non-binding advisory basis, of the compensation of our named executive officers.AgainstFOR — 3 of 4 Equitable fundsAgainstApproved, 82.0% support
Archer Aviation Inc.2026-06-26Election of Class II Directors: Barbara PilarskiWithholdFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 87.0% support
Archer Aviation Inc.2026-06-26Election of Class II Directors: Maria PinelliWithholdFOR — 3 of 4 Equitable fundsAgainstPassed (calculated), 96.6% support
OSI Systems, Inc.2025-12-11Election of Directors: William F. BallhausAgainstFOR — 4 of 6 Equitable fundsAgainstElected, 82.6% support
Worthington Enterprises, Inc.2025-09-23Approve the Worthington Enterprises, Inc. 2025 Equity Plan for Non-Employee Directors.AgainstFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 91.7% support
Worthington Enterprises, Inc.2025-09-23Elect four directors, each to serve for a term of three years to expire at the Company's 2028 Annual Meeting of Shareholders: Billy R. VickersAgainstFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 96.1% support
Worthington Enterprises, Inc.2025-09-23Elect four directors, each to serve for a term of three years to expire at the Company's 2028 Annual Meeting of Shareholders: David P. BlomAgainstFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 90.4% support
Worthington Enterprises, Inc.2025-09-23Elect four directors, each to serve for a term of three years to expire at the Company's 2028 Annual Meeting of Shareholders: Kerrii B. AndersonAgainstFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 97.7% support
Worthington Enterprises, Inc.2025-09-23Elect four directors, each to serve for a term of three years to expire at the Company's 2028 Annual Meeting of Shareholders: Paul G. HellerAgainstFOR — 4 of 6 Equitable fundsAgainstPassed (calculated), 99.5% support
The Marzetti Company2025-11-19To elect four directors, each for a term that expires in 2028: Alan F. HarrisWithholdFOR — 4 of 6 Equitable fundsAgainstElected, 92.1% support
The Marzetti Company2025-11-19To elect four directors, each for a term that expires in 2028: Barbara L. BraiserWithholdFOR — 4 of 6 Equitable fundsAgainst—
The Marzetti Company2025-11-19To elect four directors, each for a term that expires in 2028: David A. CiesinskiWithholdFOR — 4 of 6 Equitable fundsAgainstElected, 99.1% support
The Marzetti Company2025-11-19To elect four directors, each for a term that expires in 2028: Elliot K. FullenWithholdFOR — 4 of 6 Equitable fundsAgainstElected, 97.6% support
Tootsie Roll Industries, Inc.2026-05-06Election of Directors: Ellen R. GordonWithholdFOR — 3 of 4 Equitable fundsAgainstElected, 98.5% support

250 more in the CSV.

Download all 750 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 96.2% of this fund’s 8,110 such votes could be given a sector; the other 306 (3.8%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Consumer Discretionary1,799784.3%
Technology1,493634.2%
Health Care1,367151.1%
Finance1,101171.5%
Industrials1,009212.1%
Real Estate26000.0%
Consumer Staples16884.8%
Utilities16510.6%
Energy15010.7%
Miscellaneous14000.0%
Basic Materials7600.0%
Telecommunications7656.6%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections5,72725
Say-on-Pay8824
Audit-related8510
Corporate Governance28478
Compensation2814
Capital Structure850
Extraordinary Transactions570
Other Social Issues4437
Environment or Climate3332
Shareholder Rights and Defenses3314

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
NVIDIA CorporationJune 24, 2026$160M164
Apple Inc.February 24, 2026$125M121
Microsoft CorporationDecember 5, 2025$114M214
Meta Platforms, Inc.May 27, 2026$101M227
Amazon.com, Inc.May 20, 2026$80M174
Alphabet Inc.June 5, 2026$66M237
Broadcom Inc.April 20, 2026$57M100
Eli Lilly and CompanyMay 4, 2026$40M101

Notable votes against management

MeetingCompanyProposalFundMgmt
June 24, 2026NVIDIA CorporationApproval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposalForAgainst
June 24, 2026NVIDIA CorporationApproval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposalAgainstFor
February 24, 2026Apple Inc.A shareholder proposal entitled "China Entanglement Audit" Shareholder proposalAgainstFor
December 5, 2025Microsoft CorporationEuropean Security Program Censorship Risk Audit Shareholder proposalAgainstFor
December 5, 2025Microsoft CorporationReport on Risks of Censorship in Generative Artificial Intelligence Shareholder proposalAgainstFor
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposalForAgainst
May 27, 2026Meta Platforms, Inc.A shareholder proposal regarding dual class capital structure. Shareholder proposalForAgainst
May 20, 2026Amazon.com, Inc.SHAREHOLDER PROPOSAL REQUESTING A REPORT ON CHARITABLE PARTNERSHIPS Shareholder proposalAgainstFor
May 20, 2026Amazon.com, Inc.SHAREHOLDER PROPOSAL REQUESTING ADDITIONAL REPORTING ON IMPACT OF DATA CENTERS ON CLIMATE COMMITMENTS Shareholder proposalAgainstFor
June 5, 2026Alphabet Inc.Shareholder proposal regarding a report on water usage and AI development Shareholder proposalAgainstFor
June 5, 2026Alphabet Inc.Shareholder proposal regarding equal shareholder voting Shareholder proposalForAgainst
May 4, 2026Eli Lilly and CompanyShareholder proposal to prepare an annual lobbying report. Shareholder proposalAgainstFor

Contested meetings

Meetings with a proxy contest or competing nominees (3 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

8,295 ballot items at 906 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Multimanager Aggressive Equity Portfolio voted at 906 shareholder meetings of 867 companies, on 8,295 ballot items in all. Where management made a recommendation, the fund followed it on 97.0% of the items and voted against it 209 times. Its most frequent area of disagreement was corporate governance (78 of its votes against management). It voted FOR 33.7% of the 184 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals less often than Equitable's funds as a whole (85.1% against 92.5%). It voted differently from most Equitable funds on 750 items. 3 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Equitable’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.